Historical Stock Price
ETFs Holding BIIB »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
12/02/2022 $299.24 $305.06 $297.78 $298.90 1.68M
12/05/2022 $299.18 $299.70 $290.23 $292.75 1.50M
12/06/2022 $292.22 $295.07 $288.53 $291.47 1.04M
12/07/2022 $292.56 $293.60 $287.10 $292.15 1.11M
12/08/2022 $291.86 $292.32 $286.72 $289.10 1.70M
Biogen is a biopharmaceutical company focused on discovering, developing and delivering therapies for neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Co. has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA) and Alzheimer's disease. Co. also commercialize biosimilars of biologics and focuses on improving its pipeline in neuroscience and immunology. Co.'s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; ADUHELM for the treatment of Alzheimer's disease; and FUMADERM for the treatment of severe plaque psoriasis.
BIIB historical stock prices picture
Biogen (BIIB) has the following price history information. Looking back at BIIB historical stock prices for the last five trading days, on December 02, 2022, BIIB opened at $299.24, traded as high as $305.06 and as low as $297.78, and closed at $298.90. Trading volume was a total of 1.68M shares. On December 05, 2022, BIIB opened at $299.18, traded as high as $299.70 and as low as $290.23, and closed at $292.75. Trading volume was a total of 1.50M shares. On December 06, 2022, BIIB opened at $292.22, traded as high as $295.07 and as low as $288.53, and closed at $291.47. Trading volume was a total of 1.04M shares. On December 07, 2022, BIIB opened at $292.56, traded as high as $293.60 and as low as $287.10, and closed at $292.15. Trading volume was a total of 1.11M shares. On December 08, 2022, BIIB opened at $291.86, traded as high as $292.32 and as low as $286.72, and closed at $289.10. Trading volume was a total of 1.70M shares.

BIIB Historical Stock Prices By Date:

BIIB historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biogen shares, starting with a $10,000 purchase of BIIB, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/11/2012
End date: 12/08/2022
Start price/share: $154.22
End price/share: $289.10
Dividends collected/share: $0.00
Total return: 87.46%
Average Annual Total Return: 6.49%
Starting investment: $10,000.00
Ending investment: $18,750.53
Years: 10.00
Date Close
12/02/2022$298.90
12/05/2022$292.75
12/06/2022$291.47
12/07/2022$292.15
12/08/2022$289.10
BIIB is categorized under the Healthcare sector; below are some other companies in the same sector:

BIND Historical Stock Prices
BIO Historical Stock Prices
BIOC Historical Stock Prices
BIOD Historical Stock Prices
BIOL Historical Stock Prices
BIOP Historical Stock Prices
BIOS Historical Stock Prices
BIVV Historical Stock Prices
BKD Historical Stock Prices
BLCM Historical Stock Prices

Also explore: BIIB shares outstanding history

Email EnvelopeFree BIIB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

BIIB Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.